Bio/Pharmaceutical Outsourcing Report, April 2026
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from GlobalData's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for –
– CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
– Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
– Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
Learn about the past quarter’s M&A and financing deals in the manufacturing space.
Identify the latest contract service agreements.
Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Aligas Therapeutics Inc
Alzamend Neuro Inc
Amgen
AstraZeneca AB
AstraZeneca Plc
Astellas Pharma Inc
Biogen
Boehringer Ingelheim Pharma GmbH & Co KG
Bristol-Myers Squibb Co
Cambrex Corp
Catalent Germany Schorndorf GmbH
Cereno Scientific AB
Cellipont Bioservices
Cytovance Biologics Inc
DalGen
Eli Lilly
Esteve Quimica SA
FUJIFILM Biotechnologies USA Inc
Gedeon Richter Plc
GSK
Hikma Pharmaceuticals Plc
Hovione FarmaCiencia SA
Ideaya Biosciences Inc
Imunon Inc
Juzen Chemical Corp
Kincell Bio LLC
Kodiak Sciences Inc
Lifecore Biomedical LLC
Lonza Biologics Inc
Lonza Group Ltd
MAbxience Holding SL
Merck Sharp & Dohme BV
Novartis
OBiO Technology Corp Ltd
Organon & Co
Oxford Biomedica Plc
Patheon NV
PCI Pharma Services
Piramal Pharma Solutions Inc
Recipharm AB
Regeneron Pharmaceuticals Inc
Rhythm Pharmaceuticals Inc
Samsung Biologics Co Ltd
Sanofi
Scinai Immunotherapeutics Ltd
Sharp Packaging Services LLC
Symbiosis Pharmaceutical Services Ltd
Takeda
Vetter Pharma-Fertigung GmbH & Co KG
Vertex Pharmaceuticals Inc
WuXi Biologics Cayman Inc
WuXi STA Co Ltd
Table of Contents
Table
Figures
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Contract Manufacturers reports